logo
Select company
Select metric
2.85Current Ratio
VS
Market
69
Sector
46
Industry
32
History
68
$ 1.05Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 6.12M2.85$ 2.14M
3/31/2025$ 9.04M2.95$ 3.07M
12/31/2024$ 1.94M0.68$ 2.84M
9/30/2024$ 2.28M1.15$ 1.98M
6/30/2024$ 2.25M0.62$ 3.61M
3/31/2024$ 3.59M0.92$ 3.92M
12/31/2023$ 7.15M1.67$ 4.28M
9/30/2023$ 8.21M1.8$ 4.57M
6/30/2023$ 11.22M1.85$ 6.07M
3/31/2023$ 9.89M2.24$ 4.42M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) Current Ratio stands at 5.33.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average Current Ratio has been 2.76.
  • The median Current Ratio for NOVABAY PHARMACEUTICALS INC during this period was 2.64
  • NOVABAY PHARMACEUTICALS INC reached its highest Current Ratio over the past 5 years at 5.35.
  • The lowest Current Ratio recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe 0.62

NOVABAY PHARMACEUTICALS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
INM : INMED PHARMACEUTICALS INC 6.99XBIO : XENETIC BIOSCIENCES INC 5.93CNSP : CNS PHARMACEUTICALS INC 10.22ENVB : ENVERIC BIOSCIENCES INC 2.43CPHI : CHINA PHARMA HOLDINGS INC 0.51GRI : GRI BIO INC 2.41AZTR : AZITRA INC 1.24ONCO : ONCONETIX INC 0.07SPRB : SPRUCE BIOSCIENCES INC 2.6REVB : REVELATION BIOSCIENCES INC 3.42

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for NOVABAY PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 16.01M ] / LiabilitesC [ $ 3M ]
(=) Current Ratio [ 5.33 ]

NBY - Current Ratio, Last 5 years

0.62

Minimum

Jun 30, 2024

5.35

Maximum

Jun 30, 2021

2.76

Average

2.64

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44